Quick Dispatch:
Your lilly tirzepatide trial A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes (SURPASS-EARLY) orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your lilly tirzepatide trial A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes (SURPASS-EARLY) ships.
Need Help?
Questions about lilly tirzepatide trial A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes (SURPASS-EARLY), sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for lilly tirzepatide trial A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes (SURPASS-EARLY) in your area.
Lilly drug Mounjaro succeeds in second weight loss study
24.40
Lilly's Zepbound® (tirzepatide) superior to Wegovy® (semaglutide) in head-to-head trial showing an average weight loss of 20.2% vs. 13.7%
27.62
Company of the Year 2025: Eli Lilly – Among the heavyweights
26.08
Eli Lilly's Landmark Trial Shows Major Psoriasis-Obesity Breakthrough With Taltz-Zepbound Combo
22.14
Eli Lilly Finds Yet Another Condition for Zepbound to Treat. The Stock Is Up
27.73
Lilly orforglipron oral GLP-1 phase 3 weight loss trial
21.34
F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy
29.86
![Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States](https://photos.prnewswire.com/prnfull/20150421/200096)
